Oppenheimer Downgrades Procept BioRobotics Corp (PRCT) to Perform
Oppenheimer analyst Suraj Kalia downgraded Procept BioRobotics Corp (NASDAQ: PRCT) from Outperform to Perform.The analyst comments "PROCEPT reported 4Q25 revenues ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
